Genicular Artery Embolization (GAE) – a Minimally Invasive Treatment for Knee Osteoarthritis Pain

Introduction

Chronic knee pain related to osteoarthritis is one of the most common causes of disability in adults worldwide. For many patients, symptoms progress gradually over years, leading to limitations in mobility, daily activity, and overall quality of life. Traditional management typically follows a stepwise path—from physical therapy and medications to injections and, ultimately, knee replacement surgery. In recent years, however, advances in interventional radiology have introduced minimally invasive options that sit between conservative care and surgery. One of the most studied of these approaches is genicular artery embolization (GAE).

GAE is a catheter-based procedure that targets abnormal blood flow within the knee joint thought to contribute to pain and inflammation in osteoarthritis. Rather than replacing or structurally altering the joint, GAE focuses on modifying the biologic environment that drives symptoms. As clinical experience and published data continue to expand, GAE has become an increasingly discussed option for selected patients seeking pain relief without surgery.

Contact the office of Dr. Sergei Sobolevsky, or call him directly at (718) 787-5559. Dr. Sergei’s office is conveniently located in downtown Brooklyn.

What Is Genicular Artery Embolization?

Genicular artery embolization is a minimally invasive, image-guided vascular procedure performed by an interventional radiologist. The procedure involves selectively reducing blood flow through small arteries—known as the genicular arteries—that supply the inflamed synovium and periarticular tissues of the knee.

In osteoarthritis, chronic inflammation within the joint is associated with abnormal neovascularization, or the formation of small, fragile blood vessels. These vessels are believed to contribute to persistent pain by supporting inflammatory signaling and sensitizing nearby nerves. GAE aims to interrupt this cycle by embolizing (blocking) these abnormal vessels while preserving normal joint circulation.

The procedure does not involve joint replacement, cartilage removal, or surgical incisions into the knee. All treatment is performed through a tiny vascular access point, typically in the groin or wrist.

Why GAE Is Used: Clinical Rationale and Patient Profile

The rationale behind GAE is rooted in the understanding that osteoarthritis is not solely a “wear and tear” condition but also an inflammatory disease. Imaging studies and histologic research have demonstrated increased synovial blood flow in painful arthritic knees. By selectively reducing that flow, inflammation may diminish, leading to decreased pain and improved function.

GAE is most commonly considered for patients who:

• Have moderate to severe knee osteoarthritis confirmed by imaging
• Experience chronic pain that has not responded adequately to conservative therapies such as physical therapy, oral medications, or injections
• Are not ready for knee replacement surgery or wish to delay it
• Are poor surgical candidates due to medical comorbidities

Importantly, GAE is not positioned as a replacement for knee arthroplasty in patients with end-stage disease, but rather as a symptom-modifying option for those seeking alternatives before surgery becomes necessary.

How the Genicular Artery Embolization Procedure Is Performed

Pre-procedure evaluation

Before GAE, patients undergo a thorough clinical evaluation, including review of prior imaging such as X-rays or MRI scans to confirm osteoarthritis and rule out other causes of knee pain. The interventional radiologist also reviews prior treatments and assesses symptom patterns, as pain related to inflammatory activity tends to respond better than purely mechanical pain.

Vascular access and imaging

On the day of the procedure, arterial access is obtained—most commonly through the femoral artery, though radial access may be used in selected cases. Using fluoroscopic guidance, a catheter is navigated into the arteries supplying the knee joint.

Angiography allows the physician to visualize abnormal hypervascular areas associated with inflammation. These regions typically correspond to areas of pain identified during the clinical exam.

Targeted embolization

Once the abnormal vessels are identified, embolic material is delivered through a microcatheter to selectively reduce blood flow to those areas. The embolization is performed carefully to avoid non-target tissue and preserve overall joint viability.

The procedure is usually performed under local anesthesia with light to moderate sedation and typically takes one to two hours.

Post-procedure care

After embolization, the catheter is removed and the access site is closed. Patients are observed briefly and generally discharged the same day. Most resume normal activities within a few days.

Embolic Materials and Technical Considerations

GAE commonly utilizes calibrated microspheres or other particulate embolic agents designed to occlude small abnormal vessels without affecting larger, normal arteries. The choice of embolic material depends on operator preference, vascular anatomy, and desired level of distal penetration.

Precision is critical. Successful outcomes depend on detailed angiographic mapping, controlled embolic delivery, and a deep understanding of knee vascular anatomy. For this reason, the procedure should be performed by interventional radiologists with specific experience in musculoskeletal embolization.

Clinical Outcomes and Effectiveness

Multiple prospective studies, case series, and systematic reviews have demonstrated meaningful reductions in knee pain following GAE. Many patients report gradual improvement over weeks to months, with sustained symptom relief extending beyond a year in a significant proportion of cases.

Functional outcomes—such as walking tolerance and activity level—often improve alongside pain reduction. While results vary, published data consistently show favorable safety profiles and low complication rates.

As with any emerging therapy, long-term data beyond several years are still evolving, and ongoing studies continue to refine patient selection criteria and procedural techniques.

Risks and Safety Profile

GAE is generally considered safe when performed by experienced surgeons, such as Dr. Sergei Sobolevsky in downtown Brooklyn. The most common side effects include temporary knee soreness, mild swelling, or bruising at the access site. These symptoms typically resolve without intervention.

Serious complications—such as skin ischemia, nerve injury, or infection—are rare in contemporary series. Careful technique and selective embolization significantly reduce these risks. Patients are counseled that symptom relief may be partial and that repeat treatment or alternative therapies may still be required over time.

How GAE Compares With Other Knee Osteoarthritis Treatments

Conservative treatments such as physical therapy, NSAIDs, and intra-articular injections remain foundational and effective for many patients, particularly in early disease.

Knee replacement surgery offers definitive structural correction but involves significant recovery time and surgical risk. GAE occupies a middle ground—less invasive than surgery and potentially longer-lasting than injections for selected patients.

Unlike radiofrequency ablation, which targets pain-transmitting nerves, GAE addresses the inflammatory blood supply thought to drive symptoms. These approaches may be complementary rather than competitive, depending on individual patient characteristics.

Patient Selection and Limitations

Not all patients with knee osteoarthritis are ideal candidates for GAE. Those with predominantly mechanical symptoms, severe joint deformity, or advanced bone-on-bone disease may experience limited benefit. Conversely, patients with inflammatory pain patterns and imaging evidence of synovial hypervascularity tend to respond more favorably.

A multidisciplinary approach involving orthopedic specialists and interventional radiologists such as Dr. Sobolevsky in downtown Brooklyn helps ensure appropriate selection and realistic expectations.

Recovery, Follow-Up, and Long-Term Management

Following GAE, patients typically return to normal daily activities within a few days. Follow-up visits focus on symptom progression, functional improvement, and monitoring for delayed effects. Pain relief is often gradual rather than immediate, reflecting the biologic nature of the treatment.

GAE does not preclude future surgical intervention. Patients who eventually require knee replacement can still proceed without added technical difficulty related to prior embolization.

Choosing an Interventional Radiologist

GAE is a technically demanding procedure requiring expertise in vascular navigation and musculoskeletal imaging. When selecting a provider, patients should inquire about:

• Board certification in interventional radiology
• Experience with genicular artery embolization
• Procedural volume and outcomes
• Access to multidisciplinary consultation

Local Perspective: Dr. Sergei Sobolevsky in Downtown Brooklyn

For patients seeking GAE in Brooklyn, Dr. Sergei Sobolevsky is a vascular and interventional radiologist with experience in minimally invasive, image-guided procedures. He maintains an office in Downtown Brooklyn, providing local access to advanced endovascular therapies. Consultation typically involves a detailed review of imaging, prior treatments, and individual goals to determine whether GAE is an appropriate option.

Key Questions to Discuss During Consultation

Patients considering GAE may benefit from asking:

• Is my knee pain primarily inflammatory or mechanical?
• Am I a reasonable candidate for embolization?
• What level of pain relief can I realistically expect?
• How does GAE fit into my long-term treatment plan?
• What alternatives should I consider if symptoms persist?

Conclusion

Genicular artery embolization represents a thoughtful evolution in the treatment of knee osteoarthritis pain. By targeting abnormal vascular activity rather than joint structure, it offers a minimally invasive option for selected patients who seek symptom relief without surgery. While ongoing research continues to refine its role, current evidence supports GAE as a safe and effective treatment for appropriately chosen individuals

Contact Dr. Sergei Sobolevsky, or call his office in downtown Brooklyn at (718) 787-5559.